Stock Scorecard



Stock Summary for Laboratory Corp Of America Holdings (LH) - $237.85 as of 11/20/2024 8:22:54 PM EST

Total Score

13 out of 30

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for LH

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for LH

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for LH

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for LH

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for LH (57 out of 90)

Stock Price Rating (Max of 10) 10
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 9
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 1
Operating Margin (Max of 10) 2
Trading Volume (Max of 10) 5
Price to Earnings (Max of 10) 2

Latest News for for LH

Pharmacovigilance and Drug Safety Software Market Skyrockets to $359.30 Million by 2031 Dominated by Tech Giants - ArisEurope, ICON plc and Syneos Health | The Insight Partners 11/18/2024 2:10:00 PM
Fortrea Reports Third Quarter 2024 Results 11/8/2024 11:30:00 AM
LH Beats on Q3 Earnings, Raises Revenue Guidance Midpoint, Stock Gains 10/24/2024 3:12:00 PM
North America Food Testing Market Size & Share to Surpass USD 4.3 billion by 2031, as a CAGR 7.1%: Transparency Market Research, Inc. 10/21/2024 12:15:00 PM
Here's Why You Should Retain OPKO Health Stock in Your Portfolio 10/2/2024 3:54:00 PM
Clinical Trials Market to Witness 8.7% CAGR by 2031 | SkyQuest Technology 9/23/2024 12:30:00 PM
Acute Intermittent Porphyria Market Size is Projected to Reach USD 7.1 million by 2034, Growth at CAGR 3.9% | Report by Transparency Market Research, Inc. 8/27/2024 9:14:00 AM
Should You Hold Labcorp ( LH ) Stock in Your Portfolio Now? 8/22/2024 12:52:00 PM
Glenn A Eisenberg Implements A Sell Strategy: Offloads $3.36M In Labcorp Holdings Stock - Labcorp Holdings ( NYSE:LH ) 8/19/2024 3:00:00 PM
Fortrea Reports Second Quarter 2024 Results 8/12/2024 11:00:00 AM

Financial Details for LH

Company Overview

Ticker LH
Company Name Laboratory Corp Of America Holdings
Country USA
Description Laboratory Corporation of America Holdings, more commonly known as Labcorp, is an American company headquartered in Burlington, North Carolina. It operates one of the largest clinical laboratory networks in the world, with a United States network of 36 primary laboratories.
Sector Name LIFE SCIENCES
Industry Name SERVICES-MEDICAL LABORATORIES
Most Recent Quarter 9/30/2024
Next Earnings Date 2/13/2025

Stock Price History

Last Day Price 237.85
Price 4 Years Ago 169.38
Last Day Price Updated 11/20/2024 8:22:54 PM EST
Last Day Volume 476,603
Average Daily Volume 695,452
52-Week High 247.99
52-Week Low 191.37
Last Price to 52 Week Low 24.29%

Valuation Measures

Trailing PE 44.63
Industry PE 51.15
Sector PE 40.32
5-Year Average PE 12.41
Free Cash Flow Ratio 13.11
Industry Free Cash Flow Ratio 10.25
Sector Free Cash Flow Ratio 27.97
Current Ratio Most Recent Quarter 1.44
Total Cash Per Share 18.14
Book Value Per Share Most Recent Quarter 97.61
Price to Book Ratio 2.41
Industry Price to Book Ratio 1.89
Sector Price to Book Ratio 20.88
Price to Sales Ratio Twelve Trailing Months 1.55
Industry Price to Sales Ratio Twelve Trailing Months 1.70
Sector Price to Sales Ratio Twelve Trailing Months 7.11
Analyst Buy Ratings 10
Analyst Strong Buy Ratings 2

Share Statistics

Total Shares Outstanding 83,639,000
Market Capitalization 19,893,536,150
Institutional Ownership N/A

Dividends

Ex-Dividend Date 11/26/2024
Last Dividend Amount 0.72
Current Dividend Amount 0.72
Total Years Dividend Increasing 2
Trailing Annual Dividend Rate 2.88
Trailing Annual Dividend Yield 1.21%
Forward Annual Dividend Rate 3.80
Forward Annual Dividend Yield 1.60%
5-Year Dividend Payments Count 11
3-Year Average Dividend Yield 1.17%
5-Year Average Dividend Yield 1.17%
1-Year Dividend Growth Rate Percentage 33.33%
3-Year Dividend Growth Rate Percentage 279.47%
5-Year Dividend Growth Rate Percentage 31.95%
All-Time Dividend Growth Rate Percentage -5.13%
Dividend Payout Ratio 54.65%

Income Statement

Quarterly Earnings Growth YOY -5.20%
Annual Earnings Growth -67.32%
Reported EPS 12 Trailing Months 5.27
Reported EPS Past Year 11.12
Reported EPS Prior Year 14.30
Net Income Twelve Trailing Months 435,500,000
Net Income Past Year 418,000,000
Net Income Prior Year 1,279,100,000
Quarterly Revenue Growth YOY 7.40%
5-Year Revenue Growth 1.42%
Operating Margin Twelve Trailing Months 0.08

Balance Sheet

Total Cash Most Recent Quarter 1,517,300,000
Total Cash Past Year 536,800,000
Total Cash Prior Year 430,000,000
Net Cash Position Most Recent Quarter 1,516,600,000
Net Cash Position Past Year -464,900,000
Long Term Debt Past Year 1,001,700,000
Long Term Debt Prior Year 303,600,000
Total Debt Most Recent Quarter 700,000
Equity to Debt Ratio Past Year 0.89
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 7,875,000,000
Total Stockholder Equity Prior Year 10,096,600,000
Total Stockholder Equity Most Recent Quarter 8,170,200,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 843,200,000
Free Cash Flow Per Share Twelve Trailing Months 10.08
Free Cash Flow Past Year 874,100,000
Free Cash Flow Prior Year 1,474,000,000

Options

Put/Call Ratio 9.46
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 6.08
MACD Signal 4.20
20-Day Bollinger Lower Band 202.33
20-Day Bollinger Middle Band 222.61
20-Day Bollinger Upper Band 242.88
Beta 1.04
RSI 75.01
50-Day SMA 215.31
150-Day SMA 207.57
200-Day SMA 212.29

System

Modified 11/19/2024 5:25:39 AM EST